|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 25/00 | |
| A61P 35/00 | |||
| A61K 31/565 | |||
| A61K 38/17 | |||
| A61K 31/64 | |||
| A61K 31/44 | |||
| A61K 31/40 | |||
| A61K 31/549 | |||
| A61K 31/175 |
| (11) | Patento numeris | 2382977 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10010752.3 |
| Europos patento paraiškos padavimo data | 2005-09-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-11-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-08-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 610758 P | 2004-09-18 | US | |
| 698272 P | 2005-07-11 | US |
| (72) |
Simard, Marc J., US
|
| (73) |
University of Maryland, Baltimore,
Office of Research and Development 620 W. Lexington Street, 4th Floor, Baltimore, MD 21201,
US
The United States of America, as represented by the Department of Veterans Affairs, Department of Veterans Affairs Office of General Counsel - PSG IV (024) 810 Vermont Ave. N.W., Washington, DC 20420, US |
| (54) | Therapeutic agents targeting the ncca-atp channel and methods of use thereof |
| Therapeutic agents targeting the ncca-atp channel and methods of use thereof |